Clinical trials: Nevirapine
HIV Infections
Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth
The purpose of this study is to determine which of 3 different anti-HIV drug regimens given to HIV infected pregnant women during and after their pregnancies is most effective in reducing the incidence of nevirapine (NVP)…
- Trial name
- NCT00109590
- Testing
- Didanosine, enteric-coated, Lopinavir/ritonavir, Nevirapine
- Where
- 7 sites in Thailand
- Volunteers
- 175 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
Observational Non-interventional Study With Viramune® in Combination With Truvada® in HIV-infected Patients
This observational study is supposed to assess (under conditions of clinical practice in daily routine) whether treatment with Viramune (nevirapine) in combination with Truvada (tenofovir and emtricitabine) will durably suppress…
- Trial name
- NCT00543803
- Where
- 63 sites in Germany
- Volunteers
- 334 people
- Sponsor
- Boehringer Ingelheim
HIV
Moringa Oleifera- Antiretroviral Pharmacokinetic Drug Interaction
A study will be conducted by scientists from the University of Zimbabwe to determine if antiretroviral drugs are affected by taking herbs at the same time.
- Trial name
- NCT01410058
- Testing
- Moringa oleifera, Efavirenz 600mg, Nevirapine 200Mg Oral Tablet
- Where
- Zimbabwe
- Volunteers
- 19 people
- Sponsor
- University of Zimbabwe
HIV
The Rilpivirine Cerebrospinal-fluid (CSF) Study
This is a phase I pharmacokinetic study of HIV positive patients stable on antiretroviral therapy who will switch treatment when enrolled from nevirapine to rilpivirine.
- Trial name
- NCT01562886
- Testing
- Rilpivirine
- Where
- United Kingdom
- Volunteers
- 14 people
- Sponsor
- Imperial College London